共 50 条
- [32] Use of postoperative radiotherapy (PORT) for resectable non-small cell lung cancer (NSCLC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S117 - S118
- [33] ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (04): : 1066 - 1073
- [34] Targeted Therapy in Patients With Non-small Cell Lung Cancer Previously Treated With Chemotherapy MEDICINA-LITHUANIA, 2011, 47 (09): : 520 - 525
- [37] Treatment Outcomes of Radiation Therapy or Chemoradiotherapy for Postoperative Locoregional Recurrence of Non-Small Cell Lung Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E704 - E704
- [39] What is the Cause of Immune Suppression in Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S595 - S595
- [40] Postoperative Radiation Therapy (PORT) Is Associated With Better Survival in Non-Small Cell Lung Cancer With Involved N2 Lymph Nodes INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S18 - S18